A bioequivalence study comparing the pharmacokinetic profiles of budesonide delivered from the Rhinocort Aqua winged applicator and from the Rhinocort new nasal applicator (NNA) in healthy volunteers.

Study identifier:SD-005-0694

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A bioequivalence study comparing the pharmacokinetic profiles of budesonide delivered from the Rhinocort Aqua winged applicator and from the Rhinocort new nasal applicator (NNA) in healthy volunteers.

Medical condition

Allergic Rhinitis

Phase

Phase 1

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 May 2002

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2100&filename=CSR-SD-005-0694.pdf
Download
CSR-SD-005-0694.pdf
Download
Trial Results Summaries
Available here

A bioequivalence study comparing the pharmacokinetic profiles of budesonide delivered from the Rhinocort Aqua winged applicator and from the Rhinocort new nasal applicator (NNA) in healthy volunteers.

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2100&filename=CSR-SD-005-0694.pdf

CSR-SD-005-0694.pdf

Trial Results Summaries